Streetbeat News

Regulatory

PHG

Philips shares are trading lower following the FDA's statement that the company's data and analysis on recall devices were inadequate.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 10:10 am

PHG

The Center for Devices and Radiological Health (CDRH) has provided an update on Philips' June 2021 recall, maintaining its recommendations related to potential health risks of PE-PUR foam. The FDA states that the testing and analysis Philips shared are inadequate to fully evaluate the risks posed to users from recalled devices.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 10:07 am

AEHR

FRO

LEVI

LPL

PHG

PKE

In Friday's pre-market trading session, several stocks recorded losses. Park Aerospace Corp's shares fell 12.8% following its quarterly results, with earnings per share remaining the same as the previous year and sales falling. Aehr Test Systems' shares dipped 12.3% despite posting upbeat earnings and sales results for its first quarter. Koninklijke Philips N.V.'s shares declined 8% after the FDA requested more tests on its sleep apnea devices. LG Display Co., Ltd.'s shares declined 3.3% after falling 2% on Thursday. Frontline plc's shares fell 3.1% after Euronav NV confirmed that Compagnie Maritime Belge offered to acquire Frontline’s 26.12% stake. Levi Strauss & Co's shares declined 1.9% despite reporting better-than-expected earnings for its third quarter.

Portfolio Pulse from Lisa Levin

October 06, 2023 | 9:51 am

KZIA

Kazia Therapeutics shares were halted late Thursday pending an announcement by the company regarding the proposed trading solely on Nasdaq and proposed delisting of the company's securities from ASX.

Portfolio Pulse from Charles Gross

October 06, 2023 | 8:47 am

NAVB

Navidea Biopharmaceuticals is facing a trading suspension as the NYSE American Panel has upheld its decision. The company anticipates moving to OTC Markets.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 6:53 am

LAZY

Lazydays has announced an amendment to its previously announced S-1 Registration Statement for a $100M rights offering.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 6:23 am

ILMN

Illumina's GRAIL has published the final results from its PATHFINDER study, a multi-cancer early detection blood test, in The Lancet. The results could have significant implications for early cancer detection and treatment.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 6:07 am

EWG

Germany's factory orders for August have significantly exceeded estimates, coming in at 3.9% compared to the 1.8% estimate. This is a substantial improvement from the previous month's revised figure of -11.3%.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 6:03 am

EWU

The U.K. Halifax House Price Index for September shows a decrease of 0.4%, which is better than the estimated decrease of 0.8%. The prior figure was revised to -1.8%.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 6:02 am

TSLA

The U.S. Securities and Exchange Commission (SEC) has filed a lawsuit against Tesla Inc. (NASDAQ:TSLA) CEO Elon Musk, accusing him of failing to comply with a subpoena related to his 2022 Twitter stock purchase. Musk responded by calling for a comprehensive overhaul of regulatory agencies. Musk had previously expressed interest in buying all Twitter shares he didn't already own, but later changed his mind due to the prevalence of spam and fake accounts on the platform.

Portfolio Pulse from Ananya Gairola

October 06, 2023 | 5:15 am